118380-06-6

Basic information

• Product Name: METHYL N-SUCCINIMIDYL ADIPATE
• Synonyms: METHYL N-SUCCINIMIDYL ADIPATE;methyl-n-succinimidyladipat;Hexanedioic acid,1-(2,5-dioxo-1-pyrrolidinyl) 6-methyl ester;6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxo-hexanoic Acid Methyl Ester
• CAS NO: 118380-06-6
• Molecular Formula: C₁₁H₁₅NO₆
• Molecular Weight: 257.24
• Product Categories: Nitric Oxide Reagents;Cross Linking Reagents
• Mol File: 118380-06-6.mol

Chemical Properties

• Melting Point: 53°C
• Boiling Point: 356℃
• Flash Point: 169℃
• Appearance: /
• Density: 1.29
• Vapor Pressure: 3.09E-05mmHg at 25°C
• Refractive Index: 1.502
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• Stability: Moisture sensitive
• CAS DataBase Reference: METHYL N-SUCCINIMIDYL ADIPATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL N-SUCCINIMIDYL ADIPATE(118380-06-6)
• EPA Substance Registry System: METHYL N-SUCCINIMIDYL ADIPATE(118380-06-6)

Safety Data

• Hazardous Substances Data: 118380-06-6(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
METHYL N-SUCCINIMIDYL ADIPATE is used as a crosslinking reagent for the formation of covalent bonds between molecules, allowing for the creation of stable and functional products.
Used in Pharmaceutical Industry:
METHYL N-SUCCINIMIDYL ADIPATE is used as a crosslinking agent for the development of drugs, particularly in the modification of proteins and peptides to enhance their stability, solubility, and bioavailability.
Used in Research and Development:
METHYL N-SUCCINIMIDYL ADIPATE is used as a research tool for studying the interactions between biomolecules, such as proteins and peptides, and their potential applications in drug discovery and development.
Used in Diagnostics:
METHYL N-SUCCINIMIDYL ADIPATE is used as a component in the development of diagnostic tools, such as immunoassays and biosensors, where its crosslinking properties can be utilized to improve the sensitivity and specificity of these devices.
Used in Material Science:
METHYL N-SUCCINIMIDYL ADIPATE is used as a crosslinking agent in the development of advanced materials, such as polymers and composites, with improved mechanical, thermal, and chemical properties.

InChI:InChI=1/C11H15NO6/c1-17-10(15)4-2-3-5-11(16)18-12-8(13)6-7-9(12)14/h2-7H2,1H3

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 627-91-8 adipic acid monomethyl ester 

Downstream Products

• 134806-73-8 5-[(S)-1-((S)-1-Carboxy-2-methyl-propylcarbamoyl)-2-methyl-propylcarbamoyl]-pentanoic acid methyl ester 
• 402957-78-2 3,4-Dihydro-1H-isoquinoline-2-carboxylic acid (3R,5S)-5-(1-cyclopropylaminooxalyl-butylcarbamoyl)-1-{(S)-2-[(S)-2-(5-methoxycarbonyl-pentanoylamino)-3-methyl-butyrylamino]-3-methyl-butyryl}-pyrrolidin-3-yl ester 

Relevant articles and documents

P4 cap modified tetrapeptidyl α-ketoamides as potent HCV NS3 protease inhibitors

We describe herein the design, syntheses, and biological evaluation of new series of P4 tetrazole and adipic acid, ester, amide capped tetrapeptidyl α-ketoamide based HCV protease inhibitors.

Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3- acyltriazenes depends on the structure of the acyl group: Kinetic and product studies

The reactions of calf thymus DNA with ten 1-(2-chloroethyl)-3-alkyl-3- acyltriazenes of varying acyl side chain structure were studied alone, or in the presence of porcine liver esterase in pH 7.0 phosphate buffer. In several of the key triazenes, the acyl substituent contained a free carboxylic acid group. With esterase present in the reaction mixture, the resultant levels of DNA alkylation could be correlated with the kinetic rates of decomposition of the triazenes. Under these conditions, the predominant pathway of decomposition involved deacylation of the parent triazene and eventual production of an alkanediazonium ion. This intermediate subsequently alkylated DNA-guanine to give 7-alkylguanine as the principal reaction product. In the absence of esterase, the order of DNA alkylation for all of the acyltriazenes did not correlate with their respective rates of decomposition, leading to the conclusion that the triazenes did not decompose by the expected mode of uncatalyzed N(2)-N(3) heterolyic cleavage. The major DNA alkylation product from the N(3)-methyltriazenes was 7-methylguanine, instead of the expected 7-(chloroethyl)- and 7-(hydroxyethyl)guanine products, which suggested that the acyl group was being hydrolyzed. However, acyltriazenes with an N(3)-benzyl group rather than a methyl in this position produced very little 7-benzylguanine product, contrary to prediction. An alternative mechanism involving internally assisted hydrolysis of the side chain ester is proposed to explain these results. NMR product analysis and computational studies were carried out to lend support to the postulated mechanism.

Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor

High-affinity ligands for the asialoglycoprotein receptor, which is uniquely localized on the parenchymal liver cell and recognizes oligoantennary galactosides, might be utilized as homing device to specifically target drugs or genes to paranchymal liver

Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same

A phosphorus-containing analog-ligand having a stereoconfiguration that substantially corresponds to the stereoconfiguration of an amide- or ester-forming transition state is used to induce production of receptor molecules whose antibody combining sites have stereospecific amide or ester synthase catalytic activity when reacted with a ligand containing (i) a carbonyl carbon atom and (ii) an amine or alcohol group that are structurally capable of forming a preselected stereoisomer of a carboxylic amide or ester.

Antibodies which catalyze hydrolysis of ester bonds

An analog-ligand having a conformation that substantially corresponds to the conformation of a hydrolytic transition state of an amide or ester reactant ligand is used to produce receptor molecules of predetermined specificity. The receptor molecules include an antibody combining site that binds to a reactant ligand and thereby stabilizes the tetrahedral carbon atom of the amide or ester hydrolysis transition state of that reactant ligand to catalytically hydrolyze the reactant ligand at a predetermined site.

Antibody combining sites that exhibit amide or ester synthase activity

A phosphorous-containing analog-ligand having a conformation that substantially corresponds to the conformation of an amide- or ester-forming transition state is used to induce production of receptor molecules whose antibody combining sites have amide or ester synthase catalytic activity when reacted with a ligand containing (i) a carbonyl carbon atom and (ii) an amine or alcohol group that are structurally capable of forming a preselected carboxylic amide or ester bond.